DK1363614T3 - Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens - Google Patents

Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens

Info

Publication number
DK1363614T3
DK1363614T3 DK02710006T DK02710006T DK1363614T3 DK 1363614 T3 DK1363614 T3 DK 1363614T3 DK 02710006 T DK02710006 T DK 02710006T DK 02710006 T DK02710006 T DK 02710006T DK 1363614 T3 DK1363614 T3 DK 1363614T3
Authority
DK
Denmark
Prior art keywords
methanesulfonamidophenyl
hydroxy
ethanol
amino
treatment
Prior art date
Application number
DK02710006T
Other languages
Danish (da)
English (en)
Inventor
Pascale Pouzet
Hisato Kitagawa
Ikunobu Muramatsu
Franz Esser
Naoki Ishiguro
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1363614T3 publication Critical patent/DK1363614T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02710006T 2001-02-01 2002-01-15 Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens DK1363614T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
PCT/EP2002/000311 WO2002060421A2 (en) 2001-02-01 2002-01-15 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence

Publications (1)

Publication Number Publication Date
DK1363614T3 true DK1363614T3 (da) 2005-05-30

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02710006T DK1363614T3 (da) 2001-02-01 2002-01-15 Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens

Country Status (26)

Country Link
EP (1) EP1363614B1 (ja)
JP (1) JP2004517158A (ja)
KR (1) KR20030075173A (ja)
CN (1) CN1489459A (ja)
AR (1) AR035778A1 (ja)
AT (1) ATE293966T1 (ja)
BG (1) BG108033A (ja)
BR (1) BR0206854A (ja)
CA (1) CA2434565A1 (ja)
CZ (1) CZ20032097A3 (ja)
DE (2) DE10104369A1 (ja)
DK (1) DK1363614T3 (ja)
EA (1) EA200300789A1 (ja)
EC (1) ECSP034684A (ja)
EE (1) EE200300357A (ja)
ES (1) ES2240708T3 (ja)
HU (1) HUP0302752A2 (ja)
IL (1) IL156730A0 (ja)
MX (1) MXPA03006816A (ja)
NO (1) NO20033428L (ja)
PL (1) PL361731A1 (ja)
PT (1) PT1363614E (ja)
SK (1) SK9772003A3 (ja)
UY (1) UY27145A1 (ja)
WO (1) WO2002060421A2 (ja)
ZA (1) ZA200305201B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
JP6486359B2 (ja) * 2013-08-19 2019-03-20 タリス バイオメディカル エルエルシー 多ユニット薬物送達デバイス及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
FR148F (ja) * 1962-01-24
DE69113466T2 (de) * 1990-02-07 1996-03-14 Nippon Shinyaku Co Ltd Sulfonanilidderivat und arzneimittel.
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
EP0835107A1 (en) * 1995-06-02 1998-04-15 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
UY27145A1 (es) 2002-08-30
CN1489459A (zh) 2004-04-14
MXPA03006816A (es) 2004-05-14
DE60203882D1 (de) 2005-06-02
HUP0302752A2 (hu) 2003-11-28
PL361731A1 (en) 2004-10-04
NO20033428D0 (no) 2003-07-31
BG108033A (en) 2004-12-30
NO20033428L (no) 2003-09-30
EA200300789A1 (ru) 2004-02-26
WO2002060421A3 (en) 2002-12-19
CZ20032097A3 (cs) 2003-12-17
ES2240708T3 (es) 2005-10-16
JP2004517158A (ja) 2004-06-10
WO2002060421A2 (en) 2002-08-08
ZA200305201B (en) 2004-05-17
EE200300357A (et) 2003-10-15
EP1363614B1 (en) 2005-04-27
ECSP034684A (es) 2003-08-29
PT1363614E (pt) 2005-06-30
DE10104369A1 (de) 2002-08-08
BR0206854A (pt) 2004-01-13
SK9772003A3 (sk) 2005-03-04
EP1363614A2 (en) 2003-11-26
KR20030075173A (ko) 2003-09-22
CA2434565A1 (en) 2002-08-08
DE60203882T2 (de) 2006-02-02
IL156730A0 (en) 2004-02-08
AR035778A1 (es) 2004-07-14
ATE293966T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE60236093D1 (de) Entfernbarer stent
DK1604678T3 (da) Anvendelse af botulinumtoksin ved behandlingen af postoperativ smerte
NO20040778L (no) Superabsorberende polymer
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DE60205514D1 (de) Wegwerfwindel
DE60238422D1 (de) Optimierte dosierung bei paclitaxelhaltigen stents
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
DK1432701T3 (da) Heterocycliske forbindelser til anvendelse ved behandlingen af lidelser i urinvejene
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20034473L (no) Anvendelse av selektive cox-2-inhibitorer ved behandling av urininkontinens
DK1248608T3 (da) Diacerein til anvendelse i behandling af psoriasis
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DE60223576D1 (de) Hautbehandlungszusammensetzung
DK1516596T3 (da) Forbedret system til behandling af stress-urinkontinens
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
NO20030978L (no) Behandling av urindysfunksjon
DE50207870D1 (de) Abschlussbandage
DK1553952T3 (da) Anvendelse af dihydroimidazoloner til behandling af epilepsi hos hunde
DE50113918D1 (de) Quengel-Orthese
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1617876T3 (da) Thorium-227 til anvendelse i strålebehandling af bløddels-sygdomme
DK1363614T3 (da) Anvendelse af 2-amino-1-(4-hydroxy-3-methansulfonamidophenyl)ethanol til behandling af urininkontinens
NO20043614L (no) 2`-halogen-3`,5`-dialkoksyfen-1`-yl-imino-2-imidazolid in-derivater og anvendelse derav for behandling av urin-inkontinens
DK1682131T3 (da) CCI-779 til behandling af mantle-cellelymfom
DK1773451T3 (da) Anvendelse af 7-t-butoxyiminomethylcamptothecin til behandling af uterine neoplasmer